来自哲学与心理治疗领域的研究人员针对传统量表混淆哲学斯多葛主义(Stoicism)与通俗"坚忍"(stoic)概念的问题，开发了斯多葛态度与行为量表(SABS)。通过全球116国8000余样本验证，确立7因子40项结构，证实SABS能有效区分哲学斯多葛主义（与幸福感正相关）与通俗 ...

2022年11月1日, 南非标准局（SABS）宣布推出额外的SABS EMC合规证书（CoC）计划。 以前SABS只给在SABS授权实验室（SABS A-Lab）测试其产品的制造商批准EMC CoC证书。 从2022年11月1日起，制造商可使用ILAC认可实验室或SABS授权实验室（SABS A-Lab）出具的EMC报告申请SABS EMC CoC ...

SAB Biotherapeutics, Inc. (SABS) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus ...

Shares of SAB Biotherapeutics SABS plunged almost 40% on Wednesday after SABS announced discontinuing enrollment in the phase III ACTIV-2 study, which is evaluating its investigational antibody ...

Multiple analysts have issued price targets for $SABS recently. We have seen 3 analysts offer price targets for $SABS in the last 6 months, with a median target of $9 ...

To get a sense of who is truly in control of SAB Biotherapeutics, Inc. (NASDAQ:SABS), it is important to understand the ownership structure of the business. We can see that individual investors own ...

SAB Biotherapeutics Inc. Annual stock financials by MarketWatch. View the latest SABS financial statements, income statements and financial ratios.

The latest price target for SAB Biotherapeutics (NASDAQ:SABS) was reported by Chardan Capital on September 19, 2025. The analyst firm set a price target for $12.00 expecting SABS to rise to within 12 ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.